Bioequivalence and Bioavailability Forum

Main page Policy Latest Posts Abbreviations

EMA perspective: Cmax less than 5% for Test Product [Regulatives / Guidelines]

posted by d_labes – Berlin, Germany, 2013-08-20 10:28 (4691 d 03:48 ago) – Posting: # 11310
Views: 2,846

Dear Luvblooms,

for your question a) see Ohlbe's post.

—
Regards,

Detlew

Complete thread:

EMEA perspective: Cmax less than 5% for Test Product luvblooms 2013-08-20 07:01
- EMA perspective: Cmax less than 5% for Test Productd_labes 2013-08-20 08:28
  - EMA perspective: Cmax less than 5% for Test Product luvblooms 2013-08-20 10:22
  - EMA perspective: Cmax less than 5% for Test Product Dr_Dan 2013-08-20 14:21

Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
134 visitors (0 registered, 134 guests [including 13 identified bots]).
Forum time: 14:17 CEST (Europe/Vienna)

Scientists often have a naïve faith that
if only they could discover enough facts about a problem,
these facts would somehow arrange themselves
in a compelling and true solution. Theodosius Dobzhansky

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC

Ing. Helmut Schütz